Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Nov 2013

Cabrera N, Moret A, Caunedo P, Cid A R, Vila V, España F, Aznar J A

Abstract excerpt

Measuring von Willebrand factor (VWF) activity is essential for the diagnosis of von Willebrand disease (VWD). The VWF activity is usually assessed based on measurement of the ristocetin cofactor (VWF:RCo). However, that test is technically challenging and has high intra- and inter-assay variabil...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Automation
Share to VWF gene
Share to Immunoassay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Luminescent Measurements

Share to Phenotype

Share to von Willebrand Diseases

Share to von Willebrand Factor

Source

Identifiers

PMID: 23730809
DOI: 10.1111/hae.12203

Genes

VWF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23730809-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.PMID 23730809Read ↗

Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination.Semantic proximity Read ↗

Current and emerging approaches for assessing von Willebrand disease in 2016.Semantic proximity Read ↗

Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays.Semantic proximity Read ↗

Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin.Semantic proximity Read ↗

Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.Semantic proximity Read ↗

Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling.Semantic proximity Read ↗

Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.Semantic proximity Read ↗

Interest of a simple and fast method for platelet von Willebrand factor characterization.Semantic proximity Read ↗

A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.Semantic proximity Read ↗

Rapid discrimination of the phenotypic variants of von Willebrand disease.Semantic proximity Read ↗

Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.Semantic proximity Read ↗

Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.